Efficacy of levocarnitine as an add-on treatment to branched-chain amino acid-enriched nutritional supplementation on liver cirrhosis complicated by hepatic encephalopathy -a open-label study
Not Applicable
- Conditions
- iver cirrhosis
- Registration Number
- JPRN-UMIN000012096
- Lead Sponsor
- Faculty of Medical Sciences, University of Fukui
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) No administration of other test drugs within 3 months 2) No administration of other branched-chain amino acid enriched supplements 3) Severe concurrent disease 4) Pregnant and lactating females 5) Contraindication for levocarnitine and branched-chain amino acid enriched supplements 6) Inappropriate for entry onto this study in the judgment of the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method